Angelalign reworks executive incentives with option cancellation, re-grant

Angelalign Technology Inc. announced the cancellation of 1,471,435 unvested "Old Options" and the re-grant of 1,122,013 "New Options" to six "Relevant Grantees," including executive directors Mr. Song Xin and Ms. Dong Li, and four other employees. This move, effective November 24, 2025, follows a review of the company's talent strategy and industry compensation benchmarks.

Mr. Song Xin will receive 217,811 New Options, vesting 50% on April 30, 2026, and 50% on April 30, 2027. Ms. Dong Li will receive 595,689 New Options with a multi-year vesting schedule starting April 3, 2026, and concluding April 3, 2030. The four other employees will collectively receive 308,513 New Options, vesting 50% on April 30, 2026, and 50% on April 30, 2027. The exercise price for these new options is HK$64.5 per share, higher than the closing price of HK$62.65 per share on the grant date, and no performance targets are attached.

The board and remuneration committee believe this "Cancellation and Re-Grant" is an important step to recognize past contributions, motivate and retain key talent, and align the interests of shareholders, the group, and grantees. After this adjustment, 4,820,036 shares remain available for future grants under the Post-IPO Share Option Scheme.